David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$354M |
| 2 |
Wells Fargo
WFC
|
+$274M |
| 3 |
IBM
IBM
|
+$266M |
| 4 |
Qualcomm
QCOM
|
+$257M |
| 5 |
Mondelez International
MDLZ
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$356M |
| 2 |
PayPal
PYPL
|
+$290M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$261M |
| 4 |
NVIDIA
NVDA
|
+$248M |
| 5 |
AABA
Altaba Inc
AABA
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.31% |
| 2 | Healthcare | 10.66% |
| 3 | Consumer Discretionary | 10.29% |
| 4 | Communication Services | 8.78% |
| 5 | Financials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Churchill Downs
CHDN
$6.2B
| $8.77M | 0.01% |
255,120
-51,006
| -17% | -$1.63M |
|
1002
CALL
Philip Morris
PM
$302B
| $8.76M | 0.01% |
78,900
-135,300
| -63% | -$15.7M |
|
1003
Ambarella
AMBA
$3.1B
| $8.75M | 0.01% |
178,553
+49,740
| +39% | +$2.45M |
|
|
GWPH
1004
CALL
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $8.75M | 0.01% |
86,200
| – | – |
|
1005
Agnico Eagle Mines
AEM
$113B
| $8.73M | 0.01% |
193,035
-123,285
| -39% | -$5.77M |
|
1006
Southwest Gas
SWX
$6.47B
| $8.72M | 0.01% |
112,285
+774
| +0.7% | +$61.3K |
|
|
RRD
1007
DELISTED
RR Donnelley & Sons Co.
RRD
| $8.69M | 0.01% |
843,999
-378,366
| -31% | -$3.92M |
|
1008
Check Point Software Technologies
CHKP
$13.2B
| $8.68M | 0.01% |
76,116
-16,337
| -18% | -$1.8M |
|
1009
PUT
NetEase
NTES
$82.3B
| $8.65M | 0.01% |
+164,000
| New | +$9.42M |
|
1010
Progress Software
PRGS
$1.77B
| $8.65M | 0.01% |
226,677
-9,498
| -4% | -$317K |
|
1011
Interface
TILE
$2.24B
| $8.64M | 0.01% |
394,346
+8,888
| +2% | +$173K |
|
1012
CALL
Cboe Global Markets
CBOE
$32.4B
| $8.61M | 0.01% |
80,000
+37,800
| +90% | +$3.72M |
|
1013
CALL
American International
AIG
$40B
| $8.6M | 0.01% |
140,000
-252,200
| -64% | -$15.7M |
|
1014
PUT
Vulcan Materials
VMC
$35.6B
| $8.59M | 0.01% |
71,800
+14,800
| +26% | +$1.78M |
|
1015
Aflac
AFL
$58.4B
| $8.58M | 0.01% |
210,762
-339,816
| -62% | -$13.7M |
|
1016
NETGEAR
NTGR
$582M
| $8.58M | 0.01% |
180,170
+83,658
| +87% | +$3.88M |
|
1017
Live Nation Entertainment
LYV
$43.2B
| $8.57M | 0.01% |
196,716
+152,233
| +342% | +$5.91M |
|
1018
BioMarin Pharmaceuticals
BMRN
$12.8B
| $8.54M | 0.01% |
91,792
+77,126
| +526% | +$6.82M |
|
1019
Boston Beer
SAM
$1.93B
| $8.52M | 0.01% |
54,527
+51,237
| +1,557% | +$7.49M |
|
1020
CALL
National Beverage
FIZZ
$3.1B
| $8.51M | 0.01% |
137,200
+55,200
| +67% | +$3.06M |
|
1021
Regis Corp
RGS
$66.9M
| $8.48M | 0.01% |
29,712
+3,472
| +13% | +$800K |
|
1022
Mercado Libre
MELI
$101B
| $8.47M | 0.01% |
32,722
-86,921
| -73% | -$23M |
|
1023
CALL
Adobe
ADBE
$109B
| $8.4M | 0.01% |
56,300
+6,700
| +14% | +$1,000K |
|
1024
CALL
3M
MMM
$92.8B
| $8.4M | 0.01% |
47,840
-21,528
| -31% | -$3.73M |
|
|
SCG
1025
DELISTED
Scana
SCG
| $8.39M | 0.01% |
173,046
+162,529
| +1,545% | +$9.97M |
|
Similar funds
David Shaw's Q3 2017 Portfolio in Review
As of Q3 2017, David Shaw held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
David Shaw's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- David Shaw's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
- David Shaw added most to Comcast in Q3 2017, an estimated $354M increase.
- David Shaw's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
- David Shaw fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
- David Shaw's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
- David Shaw opened 469 new positions and closed 370 in Q3 2017.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $65.1B.
Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.